P. Gillard

D. Pipeleers, Z. Ling, B. Keymeulen, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Glycaemic control on nutritional support: finding stability in unstable times.

C. Mathieu, P. Gillard, Sara Charleer, 2019, The lancet. Diabetes & endocrinology.

Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost‐effective and age‐independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients

D. Pipeleers, J. Wenzlau, J. Hutton, 2013, Clinical and experimental immunology.

Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC

K. Desmet, P. Gillard, C. Harteveld, 2016, Clinical chemistry and laboratory medicine.

International Society for Pediatric and Adolescent Diabetes (ISPAD)

Louisa, Aaron J. Kowalski, B. Buckingham, 2006 .

Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes

D. Pipeleers, B. Roep, B. Keymeulen, 2016, PloS one.

Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients

C. Mathieu, D. Pipeleers, Z. Ling, 2009, Diabetes.

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

E. Bonifacio, M. Knip, D. Dunger, 2022, Trials.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.

Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation

C. Mathieu, D. Roelen, F. Claas, 2008, Clinical and experimental immunology.

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

C. Mathieu, B. Maes, D. Pipeleers, 2008, Transplantation.

Ladarixin, an inhibitor of the interleukin‐8 receptors CXCR1 and CXCR2, in new‐onset type 1 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled trial

F. Giorgino, L. Piemonti, F. Mantelli, 2022, Diabetes, obesity & metabolism.

Insulitis and lymphoid structures in the islets of Langerhans of a 66-year-old patient with long-standing type 1 diabetes

P. in’t Veld, P. Gillard, W. Staels, 2020, Virchows Archiv.

Bariatric Surgery Induces Weight Loss but Does Not Improve Glycemic Control in Patients With Type 1 Diabetes

C. Mathieu, S. Fieuws, A. D'Hoore, 2014, Diabetes Care.

Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes Patients

C. Mathieu, D. Pipeleers, Z. Ling, 2020, Transplantation.

Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

B. Alizadeh, C. Mathieu, D. Roelen, 2008, PloS one.

Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients

D. Pipeleers, Z. Ling, B. Roep, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early Alteration of Kidney Function in Nonuremic Type 1 Diabetic Islet Transplant Recipients Under Tacrolimus-Mycophenolate Therapy

C. Mathieu, D. Pipeleers, Z. Ling, 2014, Transplantation.

Predictive Factors of Allosensitization After Immunosuppressant Withdrawal in Recipients of Long-Term Cultured Islet Cell Grafts

F. Claas, D. Pipeleers, Z. Ling, 2013, Transplantation.

Immune responses against islet allografts during tapering of immunosuppression - A pilot study in 5 subjects: Immunosuppression in islet cell transplantation

D. Roelen, F. Claas, D. Pipeleers, 2012 .

Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

C. Mathieu, K. Poppe, B. Decallonne, 2009, Diabetes Care.

Allograft‐Specific Cytokine Profiles Associate with Clinical Outcome After Islet Cell Transplantation

D. Roelen, F. Claas, D. Pipeleers, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Building Classifiers to Predict the Start of Glucose-Lowering Pharmacotherapy Using Belgian Health Expenditure Data pdf

Bart De Moor, Marc Claesen, Frank De Smet, 2015, ArXiv.

Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT

C. Mathieu, A. Laenen, K. Benhalima, 2021, Diabetologia.

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.

G. Filippatos, L. Ruilope, G. Bakris, 2022, Diabetes care.

Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The RESCUE-pediatrics study

C. D. De Block, K. Casteels, P. Gillard, 2022, Frontiers in Pediatrics.

Beta-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance.

C. Mathieu, B. Maes, D. Pipeleers, 2004, Diabetes care.

Identification of Donor Origin and Condition of Transplanted Islets in Situ in the Liver of a Type 1 Diabetic Recipient

F. Claas, Z. Ling, B. Roep, 2017, Cell transplantation.

HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft

D. Pipeleers, Z. Ling, B. Roep, 2016, Diabetes Care.

Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.

Å. Lernmark, Rui Mao, C. Hampe, 2015, The Journal of clinical endocrinology and metabolism.

Feasibility, Safety, and Efficacy of Percutaneous Transhepatic Injection of β-Cell Grafts

G. Marchal, C. Mathieu, D. Pipeleers, 2005 .

Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell grafts.

G. Marchal, C. Mathieu, D. Pipeleers, 2005, Journal of vascular and interventional radiology : JVIR.

The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial.

E. Dirinck, C. D. De Block, B. Keymeulen, 2022, Journal of diabetes science and technology.

Use of hyperglycemic clamp to assess pancreatectomy and islet cell autotransplant in patient with heterotaxy syndrome and dorsal pancreas agenesis leading to chronic pancreatitis

D. Pipeleers, V. Vandecaveye, Z. Ling, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia

D. Pipeleers, Z. Ling, B. Keymeulen, 2022, Cell transplantation.

Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation.

C. Mathieu, E. Lerut, M. Lannoo, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Immune responses against islet allografts during tapering of immunosuppression – a pilot study in 5 subjects

D. Roelen, F. Claas, D. Pipeleers, 2012, Clinical and experimental immunology.

Combined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D

D. Pipeleers, S. Tersey, R. Mirmira, 2018, The Journal of clinical endocrinology and metabolism.

In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions

D. Pipeleers, J. Wenzlau, J. Hutton, 2013, Diabetologia.

Beta-cell transplantation in type 1 diabetic patients: a work in progress to cure.

C. Mathieu, B. Keymeulen, P. Gillard, 2010, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.

Insulin analogues in type 1 diabetes mellitus: getting better all the time

Pieter Gillard, C. Mathieu, K. Benhalima, 2017, Nature Reviews Endocrinology.

Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study

C. Mathieu, C. D. De Block, R. Radermecker, 2020, Diabetes Care.

Delayed Bleeding of the Transplant Duodenum After Simultaneous Kidney-pancreas Transplantation: Case Series

X. Sagaert, D. Kuypers, M. Naesens, 2020, Transplantation.

Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]

C. de Beaufort, Aaron J. Kowalski, B. Buckingham, 2021, Diabetologia.

Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

C. Mathieu, D. Pipeleers, Z. Ling, 2006, Proceedings of the National Academy of Sciences.

Cardiometabolic and Kidney Protection in Kidney Transplant Recipients With Diabetes: Mechanisms, Clinical Applications, and Summary of Clinical Trials

C. Mathieu, P. Gillard, Y. Lytvyn, 2021, Transplantation.

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

C. Mathieu, E. Araki, S. Jabbour, 2018, Diabetes Care.

CDR content 14-1

C. Mathieu, C. Gysemans, P. Gillard, 2017 .

Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient

D. Pipeleers, L. Schoonjans, Z. Ling, 2013, Diabetologia.

Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol

R. Painter, A. Laenen, K. Benhalima, 2023, BMC Pregnancy and Childbirth.

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

C. Mathieu, S. Fieuws, G. T’Sjoen, 2018, The Journal of clinical endocrinology and metabolism.

SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients

D. Pipeleers, Z. Ling, B. Roep, 2018, Diabetologia.

Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus.

D. Kuypers, P. Gillard, T. Vanhove, 2017, Transplantation reviews.

No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes

C. Mathieu, P. Gillard, K. Wierckx, 2020, Diabetes Care.

Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio

D. Pipeleers, B. Lapauw, C. D. De Block, 2017, PloS one.

Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio

D. Pipeleers, B. Lapauw, C. D. De Block, 2016, PloS one.

Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.

D. Pipeleers, J. Ruige, C. D. De Block, 2015, The Journal of clinical endocrinology and metabolism.

Utility of Technology in the Treatment of Type 1 Diabetes: Current State of the Art and Precision Evidence

I. Hirsch, M. Hulsman, M. Redondo, 2023, medRxiv.

Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort Study.

C. Mathieu, F. De Smet, P. Gillard, 2016, The Journal of clinical endocrinology and metabolism.

Stem-cell-based Therapies for Improving Islet Transplantation Outcomes in Type 1 Diabetes.

Pieter Gillard, C. Mathieu, C. Gysemans, 2017, Current diabetes reviews.

CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients

C. D. De Block, B. Keymeulen, F. Gorus, 2023, Clinical and experimental immunology.

Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.

E. Dirinck, C. D. De Block, B. Keymeulen, 2023, The lancet. Diabetes & endocrinology.

Glucose control using fast‐acting insulin aspart in a real‐world setting: A 1‐year, two‐centre study in people with type 1 diabetes using continuous glucose monitoring

C. Mathieu, E. Dirinck, C. D. De Block, 2021, Diabetes, obesity & metabolism.

Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression

C. Mathieu, D. Pipeleers, Z. Ling, 2017, Transplantation.

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

C. Mathieu, E. Dirinck, S. Fieuws, 2021, The Lancet.

Gene expression signature predicts rate of type 1 diabetes progression

Maria K. Jaakkola, E. Bonifacio, C. de Beaufort, 2023, EBioMedicine.

SARS‐CoV‐2 vaccine antibody response and breakthrough infections in transplant recipients

G. Molenberghs, F. Nevens, K. Bogaerts, 2023, Journal of medical virology.

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

C. Mathieu, D. Pipeleers, Z. Ling, 2013, Diabetes Care.

Cholestatic liver disease in long‐term infantile nephropathic cystinosis

T. Roskams, F. Nevens, D. Cassiman, 2008, Journal of gastroenterology and hepatology.

Cellular islet autoimmunity influences clinical outcome of islet cell transplantation

B. Alizadeh, C. Mathieu, D. Roelen, 2008 .

Comparative Evaluation of Simple Indices of Graft Function After Islet Transplantation

A. Secchi, A. Caumo, D. Pipeleers, 2011, Transplantation.

Sustained impact of intermittently scanned continuous glucose monitoring on treatment satisfaction and severe hypoglycemia in adults with type 1 diabetes (FUTURE) - an analysis in people with normal and impaired awareness of hypoglycemia.

C. D. De Block, P. Gillard, F. Nobels, 2023, Diabetes technology & therapeutics.

Diabetic ketoacidosis after initiation of sodium-glucose cotransporter inhibition under advanced hybrid closed-loop therapy in type 1 diabetes.

P. Gillard, C. Mathieu, Margaretha M Visser, 2022, Diabetes technology & therapeutics.

Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders

L. Piemonti, P. Pozzilli, E. Bosi, 2023, Frontiers in endocrinology.

Arresting type 1 diabetes after diagnosis: GAD is not enough

C. Mathieu, P. Gillard, 2011, The Lancet.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1)

E. Dirinck, B. Keymeulen, P. Gillard, 2022 .

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

Kristin A. Maloney, J. Pankow, L. Redman, 2023, Nature Medicine.

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

Kristin A. Maloney, J. Pankow, A. Hattersley, 2023, Communications medicine.

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

C. Mathieu, E. Araki, S. Jabbour, 2018, Diabetes Care.

Functional &bgr;-Cell Mass and Insulin Sensitivity Is Decreased in Insulin-Independent Pancreas-Kidney Recipients

C. Mathieu, B. Maes, D. Pipeleers, 2009, Transplantation.